欧美日韩亚洲一区二区三区四区 ,91尤物视频盛宴,国产综合色产在线观看,国产欧美久久久精品影院,国内精品伊人久久久影视,欧美成人精品免费播放,国产麻豆精品一区二区三区v视界

Recently, the first implantation of the Castor? Branched Aortic Stent-Graft and Delivery System (Castor? Branched Stent-Graft) and Hercules? Thoracic Stent Graft with Low Profile Delivery System covered stent (Hercules?-LP Stent Graft) developed by Endovastec?, was completed at Tan Tock Seng Hospital by Professor Glenn Tan, Professor Pua Uei, Professor Lawrence Quek, and their team. This marks the first clinical use of Endovastec?’s products in Singapore.

The patient, diagnosed with a thoracic aortic aneurysm during a preoperative assessment, had a twisted and narrowed distal neck, a lengthy affected area, a large aneurysm with a maximum diameter exceeding 70 millimeters, and exhibited noticeable symptoms. This necessitated a Thoracic Endovascular Aortic Repair (TEVAR). After a comprehensive evaluation of the patient's imaging data and related measurements, the medical team decided to perform the surgery using a combination of Castor? Branched Stent-Graft and Hercules?-LP Stent Graft, thereby establishing a more reliable, healthy anchoring zone when isolating the aneurysm.

The operation proceeded smoothly and postoperative angiography revealed precise positioning of the Castor? Branched Stent-Graft, effectively isolating the aneurysm. The near-end triple small wave segment of the stent displayed excellent sealing without any endoleak or stent migration, and the blood flow in the supra-arch branch vessels remained unobstructed, resulting in a successful surgery.

Thus far, Castor? Branched Stent-Graft has been introduced into clinical application in 16 countries worldwide, successfully treating over 18,000 patients, and Hercules?-LP Stent Graft has been introduced into clinical application in 18 countries globally, effectively treating more than 58,000 patients with aortic diseases.Endovastec? will continue its unwavering commitment to advancing comprehensive medical solutions for aortic and peripheral vascular diseases, bringing more high-quality, innovative products to global markets.

About Castor? Branched Stent-Graft and Hercules?-LP Stent Graft

Castor? Branched Stent-Graft is designed for endovascular treatment of thoracic aortic dissection involving arch lesions and is the first approved branched aortic stent-graft for the market worldwide. Meanwhile, Hercules?-LP Stent Graft adopts a Low-Profile design, which can adapt to narrower and more tortuous access arteries. It is mainly suitable for endovascular treatment of thoracic aortic aneurysm or Stanford Type B thoracic aortic dissection.